Amicus Therapeutics Inc (FOLD)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

1 CEDAR BROOK DRIVE CRANBURY, NJ 08512

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. The pharmacological chaperone technology involves the use of small molecules to restore biological activity in cells by binding to a misfolded protein caused by a genetic mutation. The company is targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Its lead compound includes Amigal, which is in Phase II clinical trials is used for the treatment of Fabry disease that causes kidney failure, cardiac abnormalities, and neurological complications. The company is also developing AT2101 for the treatment of Gaucher disease, which causes an enlarged liver and spleen, low levels of red blood cells and platelets, bone pain, and fractures; and AT2220 for the treatment of Pompe disease, which causes muscle weakness primarily affecting breathing, mobility, and heart function. The company has a strategic collaboration with Shire Human Genetic Therapies, Inc. to jointly develop pharmacological chaperone compounds for lysosomal storage disorders.

Data based on most recent fiscal year report
Market Cap2.495 Billion Shares Outstanding254.81 Million Avg Volume4.374 Million
1-Yr BETA vs S&P TR1.339 Current Ratio6.4 Quick Ratio6.3
View SEC Filings from FOLD instead.

View recent insider trading info

Funds Holding FOLD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FOLD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

286.9 Thousand total shares from 16 transactions

Exercise Derivative Conversion (M)

101 Thousand total shares from 8 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCGLYNN MARGARET G

  • Director
0 2020-01-23 2

DENTZER JAMES E PRESIDENT & CEO

  • Officer
  • Director
42,158 2020-01-23 0

GILMORE GEOFFREY GENERAL COUNSEL

  • Officer
55,783 2020-01-22 0

LOVE TED W SEE REMARKS

  • Officer
  • Director
1,066,984 2020-01-21 1

BOUDES POL F

  • Director
0 2020-01-20 0

HAYDEN DONALD J JR

0 2020-01-17 0

CROWLEY JOHN F CHAIRMAN & CEO

  • Officer
  • Director
1,023,234 2020-01-15 20

CAMPBELL BRADLEY L CHIEF OPERATING OFFICER

  • Officer
  • Director
370,520 2020-01-15 7

BARTH JAY CHIEF MEDICAL OFFICER

  • Officer
156,493 2020-01-15 9

ROSENBERG ELLEN CHIEF LEGAL OFFICER

  • Officer
200,350 2020-01-15 6

PATTERSON MATTHEW R CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-01-15 0

QUIMI DAPHNE CHIEF FINANCIAL OFFICER

  • Officer
190,422 2020-01-10 6

DO HUNG CHIEF SCIENCE OFFICER

  • Officer
521,155 2020-01-10 5

RAAB MICHAEL PRESIDENT & CEO

  • Officer
  • Director
0 2020-01-09 2

SCHAEFFER ORLOV S NICOLE CHIEF PEOPLE STRATEGY OFFICER

  • Officer
35,552 2020-01-03 0

TOPPER JAMES N

  • Director
  • 10% Owner
0 2020-01-02 0

PROUT SAMANTHA PRINCIPAL ACCOUNTING OFFICER

  • Officer
20,489 2020-01-02 2

CLARK DAVID MICHAEL CHIEF PEOPLE OFFICER

  • Officer
153,728 2020-01-02 2

GLAXOSMITHKLINE PLC

  • Director
  • 10% Owner
12,455,252 2020-01-01 0

BLOCH STEPHEN M

  • Director
2,917,169 2019-12-27 0

BARRIS PETER J

  • Director
849,527 2019-12-26 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
11,532,467 2019-12-24 1

SBLENDORIO GLENN PRESIDENT AND CEO

  • Officer
  • Director
199,804 2019-12-12 1

BARER SOL J

  • Director
0 2019-12-05 0

WHEELER CRAIG A PRESIDENT & CEO

  • Officer
  • Director
517,599 2019-12-02 1

BLEIL LYNN DORSEY

  • Director
0 2019-10-31 1

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
696,378 2019-10-29 0

ANDREWS KURT J. CHIEF HUMAN RESOURCES OFFICER

  • Officer
0 2019-09-06 0

WHITMAN BURKE W

  • Director
21,612 2019-08-23 3

BALDRY MARK CHIEF COMMERICAL OFFICER

  • Officer
39,000 2019-08-05 0

ESSNER ROBERT

  • Director
15,145 2019-06-27 1

BARRETT M JAMES

  • Director
0 2019-05-30 0

BAIRD WILLIAM D III

  • Director
0 2019-05-22 0

KRAMLICH C RICHARD

  • Director
0 2019-05-20 0

NEFF P SHERRILL

  • Director
23,839 2019-03-08 0

NEWHALL CHARLES W III

  • Director
92,298 2019-02-22 0

WEINHOFF GREGORY M PRINCIPAL FINANCIAL OFFICER

  • Officer
0 2018-03-15 0

WINTERBOTTOM JOAN CHIEF HUMAN RESOURCES OFFICER

  • Officer
47,248 2017-01-19 0

PEIST KENNETH VP, LEGAL & IP

  • Officer
18,874 2016-01-04 0

VALENZANO KEN SVP, PHARMACOLOGY & BIOLOGY

  • Officer
27,687 2015-07-13 0

DOSHI DIPAL SVP STRATEGY & BUS DEV

  • Officer
1,706 2015-07-07 0

GERSHKOWITZ JAYNE SVP, CHIEF PATIENT ADVOCATE

  • Officer
5,693 2015-07-01 0

CASTELLI JEFF SVP, PROGRAM MANAGEMENT

  • Officer
25,000 2015-06-22 0

DILONE ENRIQUE SVP, TECHNICAL OPERATIONS

  • Officer
30,688 2015-06-19 0

YU JULIE VP CLINICAL OPS & DATA MGMT

  • Officer
0 2015-06-15 0

KIRK JOHN VP, REGULATORY AFFAIRS

  • Officer
0 2015-06-01 0

DAVID ALLSOP SVP INTERNATIONAL

  • Officer
0 2015-04-27 0

LOCKHART DAVID J CHIEF SCIENTIFIC OFFICER

  • Officer
0 2013-06-18 0

MACALUSO PETER M VP & CORPORATE COUNSEL

  • Officer
0 2013-06-18 0

PERRY MARK W

  • 10% Owner
0 2012-10-17 0

WINKLER ROBERT E VP, CLIN RESEARCH & OPERATIONS

  • Officer
0 2012-06-04 0

NEW ENTERPRISE ASSOCIATES 11 LP

NEA PARTNERS 11 LP

NEA 11 GP, LLC

BASKETT FOREST

DRANT RYAN D

KOLLURI KRISHNA KITTU

SANDELL SCOTT D

  • 10% Owner
4,584,311 2012-03-07 0

BARKAS ALEXANDER E

  • Director
0 2011-05-24 0

JOHN MCADAM M VP, FINANCE & ACCOUNTING

  • Officer
0 2010-06-15 0

PALLING DAVID SR VP, TECHNICAL OPERATIONS

  • Officer
34,040 2009-06-26 0

LICHOLAI GREGORY P VP, MEDICAL AFFAIRS

  • Officer
0 2009-02-03 0

SHENKER ANDREW VP, CLINICAL RESEARCH

  • Officer
0 2009-02-03 0

FHM IV LP

FRAZIER HEALTHCARE V, LP

FHM V, LP

FHM V, LLC

FRAZIER HEALTHCARE IV LP

FRAZIER AFFILIATES IV LP

  • 10% Owner
915,924 2008-03-06 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2020-01-15 M 20,000 d 202,485 1,023,234.00 direct

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-15 S 5,064 $10.35 d 370,520 370,520.00 direct yes

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2020-01-15 S 100,000 $10.35 d 958,339 1,023,234.00 direct yes

BARTH JAY - Officer CHIEF MEDICAL OFFICER

2020-01-15 S 20,720 $10.35 d 156,473 156,493.00 direct yes

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2020-01-15 M 20,000 $5.13 a 1,058,339 1,023,234.00 direct

ROSENBERG ELLEN - Officer CHIEF LEGAL OFFICER

2020-01-15 S 22,100 $10.35 d 185,350 200,350.00 direct yes

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-10 F 29,492 $9.46 d 375,584 375,584.00 direct

BARTH JAY - Officer CHIEF MEDICAL OFFICER

2020-01-10 A 40,828 a 197,301 177,213.00 direct

ROSENBERG ELLEN - Officer CHIEF LEGAL OFFICER

2020-01-10 F 18,728 $9.46 d 207,450 222,450.00 direct

QUIMI DAPHNE - Officer CHIEF FINANCIAL OFFICER

2020-01-10 A 24,496 a 202,487 190,422.00 direct

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2020-01-10 F 64,264 $9.46 d 1,038,339 1,103,234.00 direct

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-10 A 59,881 a 405,076 375,584.00 direct

ROSENBERG ELLEN - Officer CHIEF LEGAL OFFICER

2020-01-10 A 40,828 a 226,178 222,450.00 direct

DO HUNG - Officer CHIEF SCIENCE OFFICER

2020-01-10 F 18,904 $9.46 d 521,155 521,155.00 direct

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2020-01-10 A 163,313 a 1,102,603 1,103,234.00 direct

BARTH JAY - Officer CHIEF MEDICAL OFFICER

2020-01-10 F 20,108 $9.46 d 177,193 177,213.00 direct

QUIMI DAPHNE - Officer CHIEF FINANCIAL OFFICER

2020-01-10 F 12,065 $9.46 d 190,422 190,422.00 direct

DO HUNG - Officer CHIEF SCIENCE OFFICER

2020-01-10 A 40,828 a 540,059 521,155.00 direct

MCGLYNN MARGARET G - Director

2020-01-09 M 20,000 $3.32 a 42,064 22,064.00 direct

QUIMI DAPHNE - Officer CHIEF FINANCIAL OFFICER

2020-01-09 M 1,200 $4.38 a 177,991 177,991.00 direct

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-09 M 2,500 d 20,000 345,195.00 direct

MCGLYNN MARGARET G - Director

2020-01-09 M 20,000 d 0 22,064.00 direct

QUIMI DAPHNE - Officer CHIEF FINANCIAL OFFICER

2020-01-09 M 1,200 d 7,550 177,991.00 direct

QUIMI DAPHNE - Officer CHIEF FINANCIAL OFFICER

2020-01-09 M 9,822 $2.52 a 176,791 177,991.00 direct

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-09 S 2,500 $10.01 d 345,195 345,195.00 direct yes

MCGLYNN MARGARET G - Director

2020-01-09 S 20,000 $10.00 d 22,064 22,064.00 direct yes

QUIMI DAPHNE - Officer CHIEF FINANCIAL OFFICER

2020-01-09 M 9,822 d 0 177,991.00 direct

QUIMI DAPHNE - Officer CHIEF FINANCIAL OFFICER

2020-01-09 S 15,000 $9.93 d 166,969 177,991.00 direct yes

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-09 M 2,500 $5.96 a 347,695 345,195.00 direct

BARTH JAY - Officer CHIEF MEDICAL OFFICER

2020-01-07 S 9,938 $9.36 d 156,473 156,493.00 direct yes

BARTH JAY - Officer CHIEF MEDICAL OFFICER

2020-01-06 S 6,836 $9.28 d 166,411 156,493.00 direct yes

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-03 F 13,973 $9.18 d 345,195 345,195.00 direct

ROSENBERG ELLEN - Officer CHIEF LEGAL OFFICER

2020-01-03 F 8,980 $9.18 d 185,350 200,350.00 direct

DO HUNG - Officer CHIEF SCIENCE OFFICER

2020-01-03 F 9,330 $9.18 d 499,231 499,231.00 direct

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2020-01-03 F 19,994 $9.18 d 939,290 1,004,185.00 direct

QUIMI DAPHNE - Officer CHIEF FINANCIAL OFFICER

2020-01-03 F 5,305 $9.18 d 181,969 181,969.00 direct

BARTH JAY - Officer CHIEF MEDICAL OFFICER

2020-01-03 F 9,642 $9.18 d 173,247 173,267.00 direct

DO HUNG - Officer CHIEF SCIENCE OFFICER

2020-01-02 F 7,067 $9.55 d 508,561 499,231.00 direct

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-02 M 7,500 d 22,500 359,140.00 direct

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-02 M 7,500 $5.96 a 366,640 359,140.00 direct

QUIMI DAPHNE - Officer CHIEF FINANCIAL OFFICER

2020-01-02 F 7,113 $9.55 d 187,274 181,969.00 direct

ROSENBERG ELLEN - Officer CHIEF LEGAL OFFICER

2020-01-02 A 68,446 a 211,780 216,332.00 direct

PROUT SAMANTHA - Officer PRINCIPAL ACCOUNTING OFFICER

2020-01-02 F 553 $9.55 d 20,489 20,489.00 direct

BARTH JAY - Officer CHIEF MEDICAL OFFICER

2020-01-02 S 9,753 $9.55 d 189,522 189,542.00 direct yes

CLARK DAVID MICHAEL - Officer CHIEF PEOPLE OFFICER

2020-01-02 F 5,612 $9.55 d 153,728 153,728.00 direct

BARTH JAY - Officer CHIEF MEDICAL OFFICER

2020-01-02 F 6,633 $9.55 d 182,889 173,267.00 direct

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-02 A 188,257 a 188,257 359,140.00 direct

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-02 S 14,627 $9.56 d 359,140 359,140.00 direct yes

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2020-01-02 A 403,409 a 403,409 1,024,179.00 direct

QUIMI DAPHNE - Officer CHIEF FINANCIAL OFFICER

2020-01-02 A 112,954 a 112,954 194,387.00 direct

DO HUNG - Officer CHIEF SCIENCE OFFICER

2020-01-02 A 107,575 a 107,575 515,628.00 direct

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-02 F 12,161 $9.55 d 359,168 345,195.00 direct

ROSENBERG ELLEN - Officer CHIEF LEGAL OFFICER

2020-01-02 A 107,575 a 107,575 216,332.00 direct

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-02 S 2,438 $9.56 d 371,329 371,329.00 direct yes

PROUT SAMANTHA - Officer PRINCIPAL ACCOUNTING OFFICER

2020-01-02 A 9,625 a 21,042 20,489.00 direct

BARTH JAY - Officer CHIEF MEDICAL OFFICER

2020-01-02 A 61,601 a 199,275 189,542.00 direct

CLARK DAVID MICHAEL - Officer CHIEF PEOPLE OFFICER

2020-01-02 A 58,179 a 159,340 153,728.00 direct

ROSENBERG ELLEN - Officer CHIEF LEGAL OFFICER

2020-01-02 F 7,002 $9.55 d 194,330 200,350.00 direct

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-02 S 7,500 $9.61 d 359,140 359,140.00 direct yes

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2020-01-02 A 119,780 a 373,767 359,140.00 direct

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2020-01-02 A 256,673 a 959,284 1,024,179.00 direct

QUIMI DAPHNE - Officer CHIEF FINANCIAL OFFICER

2020-01-02 A 71,868 a 194,387 194,387.00 direct

DO HUNG - Officer CHIEF SCIENCE OFFICER

2020-01-02 A 68,446 a 515,628 515,628.00 direct

ROSENBERG ELLEN - Officer CHIEF LEGAL OFFICER

2020-01-02 S 10,448 $9.56 d 201,332 216,332.00 direct yes

PROUT SAMANTHA - Officer PRINCIPAL ACCOUNTING OFFICER

2020-01-02 A 15,127 a 15,127 20,489.00 direct

BARTH JAY - Officer CHIEF MEDICAL OFFICER

2020-01-02 A 96,818 a 96,818 189,542.00 direct

CLARK DAVID MICHAEL - Officer CHIEF PEOPLE OFFICER

2020-01-02 A 91,439 a 91,439 153,728.00 direct

CAMPBELL BRADLEY L - Director - Officer CHIEF OPERATING OFFICER

2019-12-31 F 15,556 $9.74 d 253,987 359,140.00 direct

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2019-12-31 F 33,083 $9.74 d 702,611 1,024,179.00 direct

QUIMI DAPHNE - Officer CHIEF FINANCIAL OFFICER

2019-12-31 F 6,735 $9.74 d 122,519 194,387.00 direct

DO HUNG - Officer CHIEF SCIENCE OFFICER

2019-12-31 F 10,219 $9.74 d 447,182 515,628.00 direct

ROSENBERG ELLEN - Officer CHIEF LEGAL OFFICER

2019-12-31 F 10,131 $9.74 d 143,334 216,332.00 direct

BARTH JAY - Officer CHIEF MEDICAL OFFICER

2019-12-31 F 10,826 $9.74 d 137,674 189,542.00 direct

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2019-12-16 M 20,000 d 222,485 800,589.00 direct

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2019-12-16 S 20,000 $9.55 d 735,694 800,589.00 direct yes

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2019-12-16 M 20,000 $5.13 a 755,694 800,589.00 direct

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2019-12-02 M 20,000 $3.82 a 755,694 800,589.00 direct

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2019-12-02 M 20,000 d 31,439 800,589.00 direct

CROWLEY JOHN F - Director - Officer CHAIRMAN & CEO

2019-12-02 S 20,000 $10.38 d 735,694 800,589.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments